BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 2020;69:859-67. [PMID: 31852769 DOI: 10.1136/gutjnl-2019-319630] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Bi W, Cai S, Hang Z, Lei T, Wang D, Wang L, Du H. Transplantation of feces from mice with Alzheimer's disease promoted lung cancer growth. Biochemical and Biophysical Research Communications 2022;600:67-74. [DOI: 10.1016/j.bbrc.2022.01.078] [Reference Citation Analysis]
2 Madsen AMA, Halkjær SI, Christensen AH, Günther S, Browne PD, Kallemose T, Hansen LH, Petersen AM. The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study. Scand J Gastroenterol 2021;56:761-9. [PMID: 34000958 DOI: 10.1080/00365521.2021.1915375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bibbò S, Settanni CR, Porcari S, Bocchino E, Ianiro G, Cammarota G, Gasbarrini A. Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor. J Clin Med 2020;9:E1757. [PMID: 32517023 DOI: 10.3390/jcm9061757] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
4 Person H, Keefer L. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110209. [PMID: 33326819 DOI: 10.1016/j.pnpbp.2020.110209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Xu F, Li N, Wang C, Xing H, Chen D, Wei Y. Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study. BMC Gastroenterol 2021;21:54. [PMID: 33549047 DOI: 10.1186/s12876-021-01630-x] [Reference Citation Analysis]
6 Mishima Y, Ishihara S. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. Int J Mol Sci. 2020;21. [PMID: 33212919 DOI: 10.3390/ijms21228664] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
7 El-Salhy M, Patcharatrakul T, Gonlachanvit S. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century. World J Gastroenterol 2021; 27(22): 2921-2943 [PMID: 34168399 DOI: 10.3748/wjg.v27.i22.2921] [Reference Citation Analysis]
8 Cold F, Kousgaard SJ, Halkjaer SI, Petersen AM, Nielsen HL, Thorlacius-Ussing O, Hansen LH. Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis: A Systematic Review. Microorganisms 2020;8:E1433. [PMID: 32962069 DOI: 10.3390/microorganisms8091433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yau YK, Mak WYJ, Lui NSR, Ng WYR, Cheung CYK, Li YLA, Ching YLJ, Chin ML, Lau HSL, Chan KLF, Chan KSP, Ng SC. High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong. United European Gastroenterol J 2021;9:1027-38. [PMID: 34623758 DOI: 10.1002/ueg2.12160] [Reference Citation Analysis]
10 El-Salhy M, Hausken T, Hatlebakk JG. Current status of fecal microbiota transplantation for irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14157. [PMID: 34236740 DOI: 10.1111/nmo.14157] [Reference Citation Analysis]
11 Zhu LY, Huang BW, Zhang XL, Zhu N. Progress in application of probiotics, prebiotics, and synbiotics in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2022; 30(8): 375-380 [DOI: 10.11569/wcjd.v30.i8.375] [Reference Citation Analysis]
12 Frostad S, Bentz M. Anorexia nervosa: Outpatient treatment and medical management. World J Psychiatry 2022; 12(4): 558-579 [DOI: 10.5498/wjp.v12.i4.558] [Reference Citation Analysis]
13 Rezasoltani S, Yadegar A, Asadzadeh Aghdaei H, Reza Zali M. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors. Cancer Med 2021;10:1141-54. [PMID: 33369247 DOI: 10.1002/cam4.3694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wollny T, Daniluk T, Piktel E, Wnorowska U, Bukłaha A, Głuszek K, Durnaś B, Bucki R. Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome. Pathogens 2021;10:1545. [PMID: 34959500 DOI: 10.3390/pathogens10121545] [Reference Citation Analysis]
15 El-Salhy M, Valeur J, Hausken T, Gunnar Hatlebakk J. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2021;33:e13983. [PMID: 32945066 DOI: 10.1111/nmo.13983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Keller JJ, Ooijevaar RE, Hvas CL, Terveer EM, Lieberknecht SC, Högenauer C, Arkkila P, Sokol H, Gridnyev O, Mégraud F, Kump PK, Nakov R, Goldenberg SD, Satokari R, Tkatch S, Sanguinetti M, Cammarota G, Dorofeev A, Gubska O, Laniro G, Mattila E, Arasaradnam RP, Sarin SK, Sood A, Putignani L, Alric L, Baunwall SMD, Kupcinskas J, Link A, Goorhuis AG, Verspaget HW, Ponsioen C, Hold GL, Tilg H, Kassam Z, Kuijper EJ, Gasbarrini A, Mulder CJJ, Williams HRT, Vehreschild MJGT. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterol J 2021;9:229-47. [PMID: 33151137 DOI: 10.1177/2050640620967898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
17 Mogilevski T. The bi-directional role of the gut-brain axis in inflammatory and other gastrointestinal diseases. Curr Opin Gastroenterol 2021;37:572-7. [PMID: 34519701 DOI: 10.1097/MOG.0000000000000779] [Reference Citation Analysis]
18 Elhusein AM, Fadlalmola HA. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients: An Updated Systematic Review and Meta-Analysis. Gastroenterol Nurs 2022;45:11-20. [PMID: 35108241 DOI: 10.1097/SGA.0000000000000652] [Reference Citation Analysis]
19 Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A, Berentsen B. Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28(4): 412-431 [DOI: 10.3748/wjg.v28.i4.412] [Reference Citation Analysis]
20 Zeevenhooven J, de Bruijn CMA, Vlieger A, Nieuwdorp M, Benninga MA. Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial. BMJ Paediatr Open 2020;4:e000689. [PMID: 32864480 DOI: 10.1136/bmjpo-2020-000689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Segal JP, Mullish BH, Quraishi MN, Iqbal T, Marchesi JR, Sokol H. Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease. Therap Adv Gastroenterol 2020;13:1756284820946904. [PMID: 32952613 DOI: 10.1177/1756284820946904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
22 Camilleri M. Diagnosis and Treatment of Irritable Bowel Syndrome: A Review. JAMA 2021;325:865. [DOI: 10.1001/jama.2020.22532] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
23 Lin H, Guo Q, Wen Z, Tan S, Chen J, Lin L, Chen P, He J, Wen J, Chen Y. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors. Microb Cell Fact 2021;20:233. [PMID: 34963452 DOI: 10.1186/s12934-021-01720-1] [Reference Citation Analysis]
24 Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. The Lancet 2020;396:1675-88. [DOI: 10.1016/s0140-6736(20)31548-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 11] [Article Influence: 21.0] [Reference Citation Analysis]
25 Thomson P, Núñez P, Quera R, Bay C. Gastrointestinal microbiome, what is behind faecal microbiota transplantation? New Microbes New Infect 2021;42:100898. [PMID: 34168881 DOI: 10.1016/j.nmni.2021.100898] [Reference Citation Analysis]
26 Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila VJ, Tillonen J, Satokari R, Arkkila P. Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' reply. Aliment Pharmacol Ther 2020;52:557-8. [PMID: 32656839 DOI: 10.1111/apt.15875] [Reference Citation Analysis]
27 Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila V, Tillonen J, Satokari R, Arkkila P. Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Authors' reply. Aliment Pharmacol Ther 2020;52:925-6. [DOI: 10.1111/apt.15942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Singh P, Lembo A. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:523-45. [PMID: 34304786 DOI: 10.1016/j.gtc.2021.03.003] [Reference Citation Analysis]
29 . UEG Week 2020 Oral Presentations. United European Gastroenterol j 2020;8:8-142. [DOI: 10.1177/2050640620927344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Gweon TG, Lee YJ, Kim KO, Yim SK, Soh JS, Kim SY, Park JJ, Shin SY, Lee TH, Choi CH, Cho YS, Yong D, Chung JW, Lee KJ, Lee OY, Choi MG, Choi M; Gut Microbiota and Therapy Research Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea. J Neurogastroenterol Motil 2022;28:28-42. [PMID: 34980687 DOI: 10.5056/jnm21221] [Reference Citation Analysis]
31 Hillman EBM, Rijpkema S, Carson D, Arasaradnam RP, Wellington EMH, Amos GCA. Manipulating the Microbiome: An Alternative Treatment for Bile Acid Diarrhoea. Microbiology Research 2021;12:335-53. [DOI: 10.3390/microbiolres12020023] [Reference Citation Analysis]
32 Collyer R, Clancy A, Borody T. Faecal microbiota transplantation alleviates symptoms of depression in individuals with irritable bowel syndrome: A case series. Medicine in Microecology 2020;6:100029. [DOI: 10.1016/j.medmic.2020.100029] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Ianiro G, Segal JP, Mullish BH, Quraishi MN, Porcari S, Fabiani G, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders. Future Microbiol 2020;15:1173-83. [PMID: 32954843 DOI: 10.2217/fmb-2020-0061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Gerardin Y, Timberlake S, Allegretti JR, Smith MB, Kassam Z. Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome. J Infect Dis 2021;223:S276-82. [PMID: 33330910 DOI: 10.1093/infdis/jiaa700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 König J, Brummer RJ. Faecal microbiota transplantation in IBS - new evidence for success? Nat Rev Gastroenterol Hepatol 2020;17:199-200. [PMID: 32107473 DOI: 10.1038/s41575-020-0282-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Yang PL, Heitkemper MM, Kamp KJ. Irritable bowel syndrome in midlife women: a narrative review. Womens Midlife Health 2021;7:4. [PMID: 34059117 DOI: 10.1186/s40695-021-00064-5] [Reference Citation Analysis]
37 Guo Q, Lin H, Chen P, Tan S, Wen Z, Lin L, He J, Wen J, Lu S. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules. Bioengineered 2021;12:11885-97. [PMID: 34923901 DOI: 10.1080/21655979.2021.1999374] [Reference Citation Analysis]
38 Roussin L, Prince N, Perez-Pardo P, Kraneveld AD, Rabot S, Naudon L. Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence. Microorganisms 2020;8:E1369. [PMID: 32906656 DOI: 10.3390/microorganisms8091369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
39 El-Salhy M, Kristoffersen AB, Valeur J, Casen C, Hatlebakk JG, Gilja OH, Hausken T. Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14200. [PMID: 34145677 DOI: 10.1111/nmo.14200] [Reference Citation Analysis]
40 Fehily SR, Basnayake C, Wright EK, Kamm MA. Fecal microbiota transplantation therapy in Crohn's disease: Systematic review. J Gastroenterol Hepatol 2021. [PMID: 34169565 DOI: 10.1111/jgh.15598] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ghoshal UC. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment. J Gastroenterol Hepatol 2020;35:712-21. [PMID: 32162356 DOI: 10.1111/jgh.15032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
42 Doll JPK, Vázquez-castellanos JF, Schaub A, Schweinfurth N, Kettelhack C, Schneider E, Yamanbaeva G, Mählmann L, Brand S, Beglinger C, Borgwardt S, Raes J, Schmidt A, Lang UE. Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report. Front Psychiatry 2022;13:815422. [DOI: 10.3389/fpsyt.2022.815422] [Reference Citation Analysis]
43 Walls Castellanos M, Claud EC. The microbiome, guard or threat to infant health. Trends Mol Med 2021;27:1175-86. [PMID: 34518093 DOI: 10.1016/j.molmed.2021.08.002] [Reference Citation Analysis]
44 Singh P, Alm EJ, Kelley JM, Cheng V, Smith M, Kassam Z, Nee J, Iturrino J, Lembo A. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D. Gut Microbes 2022;14:2020067. [PMID: 35014601 DOI: 10.1080/19490976.2021.2020067] [Reference Citation Analysis]
45 Benech N, Sokol H. Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine. Genome Med. 2020;12:58. [PMID: 32605650 DOI: 10.1186/s13073-020-00757-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
46 Li G, Chen H, Liu L, Xiao P, Xie Y, Geng X, Zhang T, Zhang Y, Lu T, Tan H, Li L, Sun B. Role of Interleukin-17 in Acute Pancreatitis. Front Immunol 2021;12:674803. [PMID: 34594321 DOI: 10.3389/fimmu.2021.674803] [Reference Citation Analysis]
47 Camilleri M. FMT in IBS: a call for caution. Gut. 2021;70:431. [PMID: 32414814 DOI: 10.1136/gutjnl-2020-321529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms. Scand J Gastroenterol 2022;:1-10. [PMID: 35486073 DOI: 10.1080/00365521.2022.2064725] [Reference Citation Analysis]
49 El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. World J Gastroenterol 2021; 27(18): 2219-2237 [PMID: 34025075 DOI: 10.3748/wjg.v27.i18.2219] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Bajaj J, Brenner D, Cai Q, Cash B, Crowell M, Dibaise J, Gallegos-orozco J, Gardner T, Gyawali C, Ha C, Holtmann G, Jamil L, Kaplan G, Karsan H, Kinoshita Y, Lebwohl B, Leontiadis G, Lichtenstein G, Longstreth G, Muthusamy V, Oxentenko A, Pimentel M, Pisegna J, Rubenstein J, Russo M, Saini S, Samadder N, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy B. Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol 2020;115:1007-18. [DOI: 10.14309/ajg.0000000000000709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Hang L, Zhou Y, Meng YY, Feng Y, Wang YS, Yuan JY. Progress in understanding of relationship between short chain fatty acids and irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2021; 29(19): 1102-1109 [DOI: 10.11569/wcjd.v29.i19.1102] [Reference Citation Analysis]
52 Van den Houte K, Colomier E, Schol J, Carbone F, Tack J. Recent advances in diagnosis and management of irritable bowel syndrome. Curr Opin Psychiatry 2020;33:460-6. [PMID: 32639360 DOI: 10.1097/YCO.0000000000000628] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Vervier K, Moss S, Kumar N, Adoum A, Barne M, Browne H, Kaser A, Kiely CJ, Neville BA, Powell N, Raine T, Stares MD, Zhu A, De La Revilla Negro J, Lawley TD, Parkes M. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet. Gut 2021:gutjnl-2021-325177. [PMID: 34810234 DOI: 10.1136/gutjnl-2021-325177] [Reference Citation Analysis]
54 Danne C, Rolhion N, Sokol H. Recipient factors in faecal microbiota transplantation: one stool does not fit all. Nat Rev Gastroenterol Hepatol 2021;18:503-13. [PMID: 33907321 DOI: 10.1038/s41575-021-00441-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
55 Zhang Z, Wan H, Han J, Sun X, Yu R, Liu B, Lu C, Zhou J, Su X. Ameliorative effect of tuna elastin peptides on AIA mice by regulating the composition of intestinal microorganisms and SCFAs. Journal of Functional Foods 2022;92:105076. [DOI: 10.1016/j.jff.2022.105076] [Reference Citation Analysis]
56 D Goldenberg S, Merrick B. The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection. Ther Adv Infect Dis 2021;8:2049936120981526. [PMID: 33614028 DOI: 10.1177/2049936120981526] [Reference Citation Analysis]
57 Margolis KG, Cryan JF, Mayer EA. The Microbiota-Gut-Brain Axis: From Motility to Mood. Gastroenterology 2021;160:1486-501. [PMID: 33493503 DOI: 10.1053/j.gastro.2020.10.066] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
58 Bilinski J, Dziurzynski M, Grzesiowski P, Podsiadly E, Stelmaszczyk-Emmel A, Dzieciatkowski T, Dziewit L, Basak GW. Multimodal Approach to Assessment of Fecal Microbiota Donors based on Three Complementary Methods. J Clin Med 2020;9:E2036. [PMID: 32610522 DOI: 10.3390/jcm9072036] [Reference Citation Analysis]
59 Barbara G, Ianiro G. Faecal microbial transplantation in IBS: ready for prime time? Gut. 2020;69:795-796. [PMID: 32102925 DOI: 10.1136/gutjnl-2019-320411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Liang F, Lu X, Deng Z, Zhong H, Zhang W, Li Q, Zhou H, Liou Y, He X. Effect of Washed Microbiota Transplantation on Patients With Dyslipidemia in South China. Front Endocrinol 2022;13:827107. [DOI: 10.3389/fendo.2022.827107] [Reference Citation Analysis]
61 Layunta E, Buey B, Mesonero JE, Latorre E. Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis. Front Endocrinol (Lausanne) 2021;12:748254. [PMID: 34819919 DOI: 10.3389/fendo.2021.748254] [Reference Citation Analysis]
62 Tamilarasan AG, Krishnananthan T. Faecal microbiota transplantation: what's beyond Clostridium difficile infection? Eur J Gastroenterol Hepatol 2021;33:487-94. [PMID: 33177380 DOI: 10.1097/MEG.0000000000001938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Singh R, Zogg H, Ghoshal UC, Ro S. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders. Front Pharmacol 2022;13:808195. [DOI: 10.3389/fphar.2022.808195] [Reference Citation Analysis]
64 Wei L, Singh R, Ro S, Ghoshal UC. Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open 2021;5:976-87. [PMID: 34584964 DOI: 10.1002/jgh3.12528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Trakman GL, Fehily S, Basnayake C, Hamilton AL, Russell E, Wilson-O'Brien A, Kamm MA. Diet and gut microbiome in gastrointestinal disease. J Gastroenterol Hepatol 2021. [PMID: 34716949 DOI: 10.1111/jgh.15728] [Reference Citation Analysis]
66 Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol 2020;17:473-86. [DOI: 10.1038/s41575-020-0286-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
67 . Ueg Week 2020 Poster Presentations. United European Gastroenterol j 2020;8:144-887. [DOI: 10.1177/2050640620927345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
68 Corsetti M, Brown S, Chiarioni G, Dimidi E, Dudding T, Emmanuel A, Fox M, Ford AC, Giordano P, Grossi U, Henderson M, Knowles CH, O'Connell PR, Quigley EMM, Simren M, Spiller R, Whelan K, Whitehead WE, Williams AB, Scott SM. Chronic constipation in adults: Contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment. Neurogastroenterol Motil 2021;33:e14070. [PMID: 33522079 DOI: 10.1111/nmo.14070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Browne PD, Cold F, Petersen AM, Halkjær SI, Christensen AH, Günther S, Hestbjerg Hansen L. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms. Gut Microbes 2021;13:1-16. [PMID: 34074214 DOI: 10.1080/19490976.2021.1927635] [Reference Citation Analysis]
70 Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila V, Tillonen J, Satokari R, Arkkila P. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome. Aliment Pharmacol Ther 2020;51:1321-31. [DOI: 10.1111/apt.15740] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
71 Clancy AK, Lee C, Hamblin H, Gunaratne AW, LeBusque A, Beck EJ, Dawson MV, Borody TJ. Dietary Intakes of Recipients of Faecal Microbiota Transplantation: An Observational Pilot Study. Nutrients 2021;13:1487. [PMID: 33924834 DOI: 10.3390/nu13051487] [Reference Citation Analysis]
72 Mullish BH, Quraishi MN, Segal JP, Ianiro G, Iqbal TH. The gut microbiome: what every gastroenterologist needs to know. Frontline Gastroenterol 2021;12:118-27. [PMID: 33613943 DOI: 10.1136/flgastro-2019-101376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
73 Fehily SR, Basnayake C, Wright EK, Kamm MA. The gut microbiota and gut disease. Intern Med J 2021;51:1594-604. [PMID: 34664371 DOI: 10.1111/imj.15520] [Reference Citation Analysis]
74 Gupta S, Mullish BH, Allegretti JR. Fecal Microbiota Transplantation: The Evolving Risk Landscape. Am J Gastroenterol 2021;116:647-56. [PMID: 33982930 DOI: 10.14309/ajg.0000000000001075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
75 Minerbi A, Shen S. Gut Microbiome in Anesthesiology and Pain Medicine. Anesthesiology 2022. [PMID: 35486831 DOI: 10.1097/ALN.0000000000004204] [Reference Citation Analysis]
76 Hou JJ, Wang X, Wang YM, Wang BM. Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review. Crit Rev Microbiol 2021;:1-18. [PMID: 34936854 DOI: 10.1080/1040841X.2021.2018401] [Reference Citation Analysis]
77 Dixit K, Chaudhari D, Dhotre D, Shouche Y, Saroj S. Restoration of dysbiotic human gut microbiome for homeostasis. Life Sci 2021;278:119622. [PMID: 34015282 DOI: 10.1016/j.lfs.2021.119622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
78 Wu J, Lv L, Wang C. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials. Front Cell Infect Microbiol 2022;12:827395. [DOI: 10.3389/fcimb.2022.827395] [Reference Citation Analysis]
79 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol 2021. [PMID: 34735024 DOI: 10.1111/jgh.15731] [Reference Citation Analysis]
80 Segal JP, Mullish BH, Quraishi MN, Iqbal TH. Letter: faecal microbiota transplantation for IBS. Aliment Pharmacol Ther. 2020;52:556-557. [PMID: 32656836 DOI: 10.1111/apt.15824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
81 Sung JJY, Wong SH. What is unknown in using microbiota as a therapeutic? J Gastroenterol Hepatol 2021. [PMID: 34668228 DOI: 10.1111/jgh.15716] [Reference Citation Analysis]
82 Shao HQ, Tan ZJ. Microbiota-targeted therapeutics in gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2021; 29(15): 841-848 [DOI: 10.11569/wcjd.v29.i15.841] [Reference Citation Analysis]
83 Wei S, Bahl MI, Baunwall SMD, Hvas CL, Licht TR. Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances. Appl Environ Microbiol 2021;87:e00395-21. [PMID: 33741632 DOI: 10.1128/AEM.00395-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Waldum H, Martinsen TC. Chronic diseases: what about infections of virus and prions via the gut? Therap Adv Gastroenterol 2021;14:17562848211028805. [PMID: 34603505 DOI: 10.1177/17562848211028805] [Reference Citation Analysis]
85 Núñez F P, Quera R, Bay C, Thomson P. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. Gastroenterol Hepatol 2021:S0210-5705(21)00192-8. [PMID: 34118321 DOI: 10.1016/j.gastrohep.2021.05.009] [Reference Citation Analysis]
86 Mazzawi T, El-Salhy M, Lied GA, Hausken T. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Front Cell Infect Microbiol 2021;11:524851. [PMID: 34055657 DOI: 10.3389/fcimb.2021.524851] [Reference Citation Analysis]
87 Edwinson AL, Yang L, Peters S, Hanning N, Jeraldo P, Jagtap P, Simpson JB, Yang TY, Kumar P, Mehta S, Nair A, Breen-Lyles M, Chikkamenahalli L, Graham RP, De Winter B, Patel R, Dasari S, Kashyap P, Griffin T, Chen J, Farrugia G, Redinbo MR, Grover M. Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome. Nat Microbiol 2022;7:680-94. [PMID: 35484230 DOI: 10.1038/s41564-022-01103-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 El-Salhy M, Patcharatrakul T, Gonlachanvit S. The role of diet in the pathophysiology and management of irritable bowel syndrome. Indian J Gastroenterol 2021;40:111-9. [PMID: 33666892 DOI: 10.1007/s12664-020-01144-6] [Reference Citation Analysis]
89 Holvoet T, Joossens M, Vázquez-castellanos JF, Christiaens E, Heyerick L, Boelens J, Verhasselt B, van Vlierberghe H, De Vos M, Raes J, De Looze D. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial. Gastroenterology 2021;160:145-157.e8. [DOI: 10.1053/j.gastro.2020.07.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
90 Cheng YW, Fischer M. Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime? Gastroenterol Clin North Am 2020;49:739-52. [PMID: 33121693 DOI: 10.1016/j.gtc.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 El-Salhy M. FMT in IBS: how cautious should we be? Gut. 2021;70:626-628. [PMID: 32665338 DOI: 10.1136/gutjnl-2020-322038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Singh R, Zogg H, Wei L, Bartlett A, Ghoshal UC, Rajender S, Ro S. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.J Neurogastroenterol Motil. 2021;27:19-34. [PMID: 33166939 DOI: 10.5056/jnm20149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
93 Cui J, Lin Z, Tian H, Yang B, Zhao D, Ye C, Li N, Qin H, Chen Q. Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study. Front Med (Lausanne) 2021;8:710452. [PMID: 34395484 DOI: 10.3389/fmed.2021.710452] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Wilmes L, Collins JM, O'Riordan KJ, O'Mahony SM, Cryan JF, Clarke G. Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome. Neurogastroenterol Motil 2021;33:e14095. [PMID: 33580895 DOI: 10.1111/nmo.14095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
95 Nee J, Lembo A. Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS-D) and IBS mixed pattern (IBS-M). Aliment Pharmacol Ther 2021;54 Suppl 1:S63-74. [PMID: 34927757 DOI: 10.1111/apt.16625] [Reference Citation Analysis]
96 Bousdouni P, Kandyliari A, Koutelidakis AE. Probiotics and Phytochemicals: Role on Gut Microbiota and Efficacy on Irritable Bowel Syndrome, Functional Dyspepsia, and Functional Constipation. Gastrointestinal Disorders 2022;4:30-48. [DOI: 10.3390/gidisord4010005] [Reference Citation Analysis]
97 Ianiro G, Porcari S, Ford AC, Gasbarrini A, Cammarota G. Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Aliment Pharmacol Ther. 2020;52:923-924. [PMID: 32852834 DOI: 10.1111/apt.15923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Su F, Luo Y, Yu J, Shi J, Zhao Y, Yan M, Huang H, Tan Y. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review. Eur J Med Res 2021;26:37. [PMID: 33910622 DOI: 10.1186/s40001-021-00508-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Baunwall SMD, Dahlerup JF, Engberg JH, Erikstrup C, Helms M, Juel MA, Kjeldsen J, Nielsen HL, Nilsson AC, Rode AA, Vinter-Jensen L, Hvas CL. Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT). Scand J Gastroenterol 2021;56:1056-77. [PMID: 34261379 DOI: 10.1080/00365521.2021.1922749] [Reference Citation Analysis]
100 Tu T, Zhao C. Treating autism spectrum disorder by intervening with gut microbiota. J Med Microbiol 2021;70. [PMID: 34898421 DOI: 10.1099/jmm.0.001469] [Reference Citation Analysis]
101 Green JE, Davis JA, Berk M, Hair C, Loughman A, Castle D, Athan E, Nierenberg AA, Cryan JF, Jacka F, Marx W. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes 2020;12:1-25. [PMID: 33345703 DOI: 10.1080/19490976.2020.1854640] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]